AVITA Medical Schedules Investor Webinar to Discuss 2025 Financial Results

  • AVITA Medical will host an investor webinar on February 18, 2026, at 2:00 p.m. PST (February 19, 2026, at 9:00 a.m. AEDT) to discuss its fourth-quarter and full-year 2025 financial results.
  • The webinar will be led by Cary Vance, Interim CEO, and David O’Toole, CFO.
  • Participants can submit questions via the registration page.
  • A replay will be available on AVITA Medical’s investor relations website.

AVITA Medical’s investor webinar comes at a critical juncture as the company seeks to solidify its position in the therapeutic acute wound care market. With its RECELL technology and other products gaining regulatory approvals globally, the company is poised to capitalize on expanding market opportunities. The webinar will provide insights into AVITA Medical’s financial health and strategic initiatives, which are essential for investors assessing its growth potential.

Financial Performance
How AVITA Medical’s 2025 financial results will impact investor confidence and stock performance.
Leadership Transition
Whether Cary Vance, as Interim CEO, can provide clear strategic direction and stability.
Market Expansion
The pace at which AVITA Medical can scale its international operations, particularly in Europe, Australia, and Japan.